{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T10:33:06Z","timestamp":1794825186570,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DA041294"],"award-info":[{"award-number":["K23DA041294"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24DA034621"],"award-info":[{"award-number":["K24DA034621"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37DA013806"],"award-info":[{"award-number":["R37DA013806"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA16065"],"award-info":[{"award-number":["R01DA16065"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01DA036935"],"award-info":[{"award-number":["U01DA036935"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA036927"],"award-info":[{"award-number":["DA036927"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA048063"],"award-info":[{"award-number":["DA048063"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AI094189"],"award-info":[{"award-number":["P30AI094189"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","award":["Doris Duke Early Clinician Investigator Award"],"award-info":[{"award-number":["Doris Duke Early Clinician Investigator Award"]}],"id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The availability of effective, oral direct acting antivirals (DAAs) for hepatitis C virus (HCV) treatment has put elimination of HCV as a public health challenge within reach. However, little is known about the characteristics of transmission networks of people who inject drugs (PWID).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Sequencing of a segment of the HCV genome was performed on samples collected from a community-based cohort of PWID between August 2005 and December 2016. Phylogenetic trees were inferred, and clusters were identified (70% bootstrap threshold; 0.04 maximum genetic distance threshold). We describe sex, race, age difference, and HIV infection status of potential transmission partners. Logistic regression was used to assess factors associated with being in an HCV cluster.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 508 HCV genotype 1 viremic PWID, 8% (<jats:italic>n<\/jats:italic>\u00a0=\u200941) were grouped into 20 clusters, consisting of 19 pairs and 1 triad. In adjusted analyses, female sex (odds ratio [OR] 2.3 [95% confidence interval (CI) 1.2\u20134.5]) and HIV infection (OR 5.7 [CI 2.7\u201311.9]) remained independently associated with being in an HCV infection cluster.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Molecular epidemiological analysis reveals that, in this cohort of PWID in Baltimore, HIV infection and female sex were associated with HCV clustering. Combination HCV prevention interventions targeting HIV infected PWID and addressing HCV infection prevention needs of women have potential to advance HCV elimination efforts.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-020-05546-x","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:09:00Z","timestamp":1604966940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2321-2295","authenticated-orcid":false,"given":"Oluwaseun","family":"Falade-Nwulia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jada","family":"Hackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti H.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean D.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sulkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Latkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Laeyendecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart C.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"issue":"Suppl 5","key":"5546_CR1","doi-asserted-by":"publisher","first-page":"S263","DOI":"10.1086\/427440","volume":"40","author":"MS Sulkowski","year":"2005","unstructured":"Sulkowski MS, Thomas DL. Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment. Clin Infect Dis. 2005;40(Suppl 5):S263\u20139.","journal-title":"Clin Infect Dis."},{"issue":"5","key":"5546_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/infdis\/jiq112","volume":"203","author":"SH Mehta","year":"2011","unstructured":"Mehta SH, Astemborski J, Kirk GD, Strathdee SA, Nelson KE, Vlahov D, et al. Changes in blood-borne infection risk among injection drug users. J Infect Dis. 2011;203(5):587\u201394.","journal-title":"J Infect Dis"},{"issue":"7","key":"5546_CR3","doi-asserted-by":"publisher","first-page":"e103345","DOI":"10.1371\/journal.pone.0103345","volume":"9","author":"L Wiessing","year":"2014","unstructured":"Wiessing L, Ferri M, Grady B, Kantzanou M, Sperle I, Cullen KJ, et al. Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention. PLoS One. 2014;9(7):e103345.","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"5546_CR4","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1093\/cid\/cit300","volume":"57","author":"K Page","year":"2013","unstructured":"Page K, Morris MD, Hahn JA, Maher L, Prins M. Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis. 2013;57(Suppl 2):S32\u20138.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"5546_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/cid\/ciw869","volume":"64","author":"MD Morris","year":"2017","unstructured":"Morris MD, Shiboski S, Bruneau J, Hahn JA, Hellard M, Prins M, et al. Geographic differences in temporal incidence trends of hepatitis C virus infection among people who inject drugs: the InC3 collaboration. Clin Infect Dis. 2017;64(7):860\u20139.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5546_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jech.57.4.310","volume":"57","author":"BP Smyth","year":"2003","unstructured":"Smyth BP, O'Connor JJ, Barry J, Keenan E. Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin. J Epidemiol Community Health. 2003;57(4):310\u20131.","journal-title":"J Epidemiol Community Health"},{"issue":"2","key":"5546_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","volume":"108","author":"JE Zibbell","year":"2018","unstructured":"Zibbell JE, Asher AK, Patel RC, Kupronis B, Iqbal K, Ward JW, et al. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health. 2018;108(2):175\u201381.","journal-title":"Am J Public Health"},{"issue":"10","key":"5546_CR8","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/cid\/ciw111","volume":"62","author":"KN Ly","year":"2016","unstructured":"Ly KN, Hughes EM, Jiles RB, Holmberg SD. Rising mortality associated with hepatitis C virus in the United States, 2003-2013. Clin infect Dis. 2016;62(10):1287\u20138.","journal-title":"Clin infect Dis"},{"key":"5546_CR9","volume-title":"Draft global health sector strategy on viral hepatitis, 2016\u20132021- The first of it's kind","author":"World Health Organization","year":"2015","unstructured":"World Health Organization: Draft global health sector strategy on viral hepatitis, 2016\u20132021- The first of it's kind. 2015."},{"key":"5546_CR10","volume-title":"A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington (DC)","year":"2017","unstructured":"Strom BL, Buckley GJ, editors. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington (DC) 2017."},{"issue":"3","key":"5546_CR11","doi-asserted-by":"publisher","first-page":"e1001610","DOI":"10.1371\/journal.pmed.1001610","volume":"11","author":"MK Grabowski","year":"2014","unstructured":"Grabowski MK, Lessler J, Redd AD, Kagaayi J, Laeyendecker O, Ndyanabo A, et al. The role of viral introductions in sustaining community-based HIV epidemics in rural Uganda: evidence from spatial clustering, phylogenetics, and egocentric transmission models. PLoS Med. 2014;11(3):e1001610.","journal-title":"PLoS Med"},{"issue":"3","key":"5546_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa1515195","volume":"375","author":"PJ Peters","year":"2016","unstructured":"Peters PJ, Pontones P, Hoover KW, Patel MR, Galang RR, Shields J, et al. HIV infection linked to injection use of Oxymorphone in Indiana, 2014-2015. N Engl J Med. 2016;375(3):229\u201339.","journal-title":"N Engl J Med"},{"issue":"12","key":"5546_CR13","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1093\/infdis\/jir651","volume":"204","author":"SH Eshleman","year":"2011","unstructured":"Eshleman SH, Hudelson SE, Redd AD, Wang L, Debes R, Chen YQ, et al. Analysis of genetic linkage of HIV from couples enrolled in the HIV prevention trials network 052 trial. J Infect Dis. 2011;204(12):1918\u201326.","journal-title":"J Infect Dis"},{"issue":"10","key":"5546_CR14","doi-asserted-by":"publisher","first-page":"e47335","DOI":"10.1371\/journal.pone.0047335","volume":"7","author":"R Sacks-Davis","year":"2012","unstructured":"Sacks-Davis R, Daraganova G, Aitken C, Higgs P, Tracy L, Bowden S, et al. Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs. PLoS One. 2012;7(10):e47335.","journal-title":"PLoS One"},{"key":"5546_CR15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ebiom.2018.10.007","volume":"37","author":"S Ramachandran","year":"2018","unstructured":"Ramachandran S, Thai H, Forbi JC, Galang RR, Dimitrova Z, Xia GL, et al. A large HCV transmission network enabled a fast-growing HIV outbreak in rural Indiana, 2015. EBioMedicine. 2018;37:374\u201381.","journal-title":"EBioMedicine."},{"key":"5546_CR16","first-page":"75","volume":"109","author":"D Vlahov","year":"1991","unstructured":"Vlahov D, Anthony JC, Munoz A, Margolick J, Nelson KE, Celentano DD, et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr. 1991;109:75\u2013100.","journal-title":"NIDA Res Monogr"},{"issue":"3","key":"5546_CR17","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1086\/315786","volume":"182","author":"SC Ray","year":"2000","unstructured":"Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis. 2000;182(3):698\u2013707.","journal-title":"J Infect Dis"},{"issue":"23","key":"5546_CR18","doi-asserted-by":"publisher","first-page":"12582","DOI":"10.1128\/JVI.01440-12","volume":"86","author":"JR Bailey","year":"2012","unstructured":"Bailey JR, Laskey S, Wasilewski LN, Munshaw S, Fanning LJ, Kenny-Walsh E, et al. Constraints on viral evolution during chronic hepatitis C virus infection arising from a common-source exposure. J Virol. 2012;86(23):12582\u201390.","journal-title":"J Virol"},{"issue":"9","key":"5546_CR19","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/bioinformatics\/btu033","volume":"30","author":"A Stamatakis","year":"2014","unstructured":"Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014;30(9):1312\u20133.","journal-title":"Bioinformatics."},{"issue":"6","key":"5546_CR20","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/sysbio\/sys062","volume":"61","author":"DH Huson","year":"2012","unstructured":"Huson DH, Scornavacca C. Dendroscope 3: an interactive tool for rooted phylogenetic trees and networks. Syst Biol. 2012;61(6):1061\u20137.","journal-title":"Syst Biol"},{"issue":"9","key":"5546_CR21","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/bioinformatics\/14.9.817","volume":"14","author":"D Posada","year":"1998","unstructured":"Posada D, Crandall KA. MODELTEST: testing the model of DNA substitution. Bioinformatics. 1998;14(9):817\u20138.","journal-title":"Bioinformatics."},{"key":"5546_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/1471-2105-14-317","volume":"14","author":"M Ragonnet-Cronin","year":"2013","unstructured":"Ragonnet-Cronin M, Hodcroft E, Hue S, Fearnhill E, Delpech V, Brown AJ, et al. Automated analysis of phylogenetic clusters. BMC Bioinformatics. 2013;14:317.","journal-title":"BMC Bioinformatics"},{"key":"5546_CR23","doi-asserted-by":"publisher","first-page":"104078","DOI":"10.1016\/j.meegid.2019.104078","volume":"77","author":"J Hackman","year":"2020","unstructured":"Hackman J, Falade-Nwulia O, Patel EU, Mehta SH, Kirk GD, Astemborski J, et al. Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore. Infect Genet Evol. 2020;77:104078.","journal-title":"Infect Genet Evol"},{"issue":"5","key":"5546_CR24","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/hep.27310","volume":"60","author":"B Jacka","year":"2014","unstructured":"Jacka B, Applegate T, Krajden M, Olmstead A, Harrigan PR, Marshall B, et al. Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver. Canada Hepatol. 2014;60(5):1571\u201380.","journal-title":"Canada Hepatol"},{"key":"5546_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.meegid.2015.11.028","volume":"37","author":"SR Bartlett","year":"2016","unstructured":"Bartlett SR, Jacka B, Bull RA, Luciani F, Matthews GV, Lamoury FM, et al. HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection. Infect Genet Evol. 2016;37:252\u20138.","journal-title":"Infect Genet Evol"},{"issue":"6","key":"5546_CR26","doi-asserted-by":"publisher","first-page":"e97726","DOI":"10.1371\/journal.pone.0097726","volume":"9","author":"J Grebely","year":"2014","unstructured":"Grebely J, Lima VD, Marshall BD, Milloy MJ, DeBeck K, Montaner J, et al. Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012. PLoS One. 2014;9(6):e97726.","journal-title":"PLoS One"},{"issue":"6","key":"5546_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/cid\/ciq200","volume":"52","author":"GV Matthews","year":"2011","unstructured":"Matthews GV, Pham ST, Hellard M, Grebely J, Zhang L, Oon A, et al. Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C. Clin Infect Dis. 2011;52(6):803\u201311.","journal-title":"Clin Infect Dis"},{"issue":"18","key":"5546_CR28","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1001\/jama.287.18.2406","volume":"287","author":"MS Sulkowski","year":"2002","unstructured":"Sulkowski MS, Ray SC, Thomas DL. Needlestick transmission of hepatitis C. JAMA. 2002;287(18):2406\u201313.","journal-title":"JAMA."},{"issue":"12","key":"5546_CR29","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1111\/add.12682","volume":"109","author":"S Nolan","year":"2014","unstructured":"Nolan S, Dias Lima V, Fairbairn N, Kerr T, Montaner J, Grebely J, et al. The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users. Addiction. 2014;109(12):2053\u20139.","journal-title":"Addiction."},{"issue":"3","key":"5546_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/add.14012","volume":"113","author":"L Platt","year":"2018","unstructured":"Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane review and meta-analysis. Addiction. 2018;113(3):545\u201363.","journal-title":"Addiction."},{"issue":"11","key":"5546_CR31","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","volume":"106","author":"KM Turner","year":"2011","unstructured":"Turner KM, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011;106(11):1978\u201388.","journal-title":"Addiction."},{"issue":"8","key":"5546_CR32","doi-asserted-by":"publisher","first-page":"e104515","DOI":"10.1371\/journal.pone.0104515","volume":"9","author":"NE Palmateer","year":"2014","unstructured":"Palmateer NE, Taylor A, Goldberg DJ, Munro A, Aitken C, Shepherd SJ, et al. Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions. PLoS One. 2014;9(8):e104515.","journal-title":"PLoS One"},{"issue":"3","key":"5546_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/09595230701247731","volume":"26","author":"J Bryant","year":"2007","unstructured":"Bryant J, Treloar C. The gendered context of initiation to injecting drug use: evidence for women as active initiates. Drug Alcohol Rev. 2007;26(3):287\u201393.","journal-title":"Drug Alcohol Rev"},{"key":"5546_CR34","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.drugalcdep.2013.10.013","volume":"134","author":"AM Young","year":"2014","unstructured":"Young AM, Larian N, Havens JR. Gender differences in circumstances surrounding first injection experience of rural injection drug users in the United States. Drug Alcohol Depend. 2014;134:401\u20135.","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"5546_CR35","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.addbeh.2010.06.007","volume":"35","author":"M Dunn","year":"2010","unstructured":"Dunn M, Degenhardt L, Bruno R. Transition to and from injecting drug use among regular ecstasy users. Addict Behav. 2010;35(10):909\u201312.","journal-title":"Addict Behav"},{"issue":"5","key":"5546_CR36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3109\/10826089609045825","volume":"31","author":"B Powis","year":"1996","unstructured":"Powis B, Griffiths P, Gossop M, Strang J. The differences between male and female drug users: community samples of heroin and cocaine users compared. Subst Use Misuse. 1996;31(5):529\u201343.","journal-title":"Subst Use Misuse"},{"issue":"3","key":"5546_CR37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.drugalcdep.2004.08.021","volume":"77","author":"LA Novelli","year":"2005","unstructured":"Novelli LA, Sherman SG, Havens JR, Strathdee SA, Sapun M. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users. Drug Alcohol Depend. 2005;77(3):303\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"5546_CR38","doi-asserted-by":"publisher","first-page":"507214","DOI":"10.1155\/2015\/507214","volume":"2015","author":"A Guichard","year":"2015","unstructured":"Guichard A, Guignard R, Lert F, Roy E. Risk factors associated with unsafe injection practices at the first injection episode among intravenous drug users in France: results from PrimInject, an internet survey. J Addict. 2015;2015:507214.","journal-title":"J Addict"},{"issue":"10","key":"5546_CR39","doi-asserted-by":"publisher","first-page":"e109282","DOI":"10.1371\/journal.pone.0109282","volume":"9","author":"MD Morris","year":"2014","unstructured":"Morris MD, Evans J, Montgomery M, Yu M, Briceno A, Page K, et al. Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco. CA PLoS One. 2014;9(10):e109282.","journal-title":"CA PLoS One"},{"issue":"1","key":"5546_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/jrh.12256","volume":"34","author":"M Staton","year":"2018","unstructured":"Staton M, Ciciurkaite G, Havens J, Tillson M, Leukefeld C, Webster M, et al. Correlates of injection drug use among rural Appalachian women. J Rural Health. 2018;34(1):31\u201341.","journal-title":"J Rural Health"},{"issue":"5","key":"5546_CR41","doi-asserted-by":"publisher","first-page":"e004988","DOI":"10.1136\/bmjopen-2014-004988","volume":"4","author":"D Tracy","year":"2014","unstructured":"Tracy D, Hahn JA, Fuller Lewis C, Evans J, Briceno A, Morris MD, et al. Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO study cohort. BMJ Open. 2014;4(5):e004988.","journal-title":"BMJ Open"},{"key":"5546_CR42","volume-title":"Surveillance for viral hepatitis \u2013 United States, 2017","author":"Prevention CfDCa","year":"2019","unstructured":"Prevention CfDCa. Surveillance for viral hepatitis \u2013 United States, 2017. 2019."},{"issue":"9","key":"5546_CR43","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1086\/424678","volume":"190","author":"CK Aitken","year":"2004","unstructured":"Aitken CK, McCaw RF, Bowden DS, Tracy SL, Kelsall JG, Higgs PG, et al. Molecular epidemiology of hepatitis C virus in a social network of injection drug users. J Infect Dis. 2004;190(9):1586\u201395.","journal-title":"J Infect Dis"},{"issue":"4","key":"5546_CR44","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1365-2893.2010.01297.x","volume":"18","author":"VD Hope","year":"2011","unstructured":"Hope VD, Hickman M, Ngui SL, Jones S, Telfer M, Bizzarri M, et al. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. J Viral Hepat. 2011;18(4):262\u201370.","journal-title":"J Viral Hepat"},{"issue":"7","key":"5546_CR45","doi-asserted-by":"publisher","first-page":"e22245","DOI":"10.1371\/journal.pone.0022245","volume":"6","author":"R Pilon","year":"2011","unstructured":"Pilon R, Leonard L, Kim J, Vallee D, De Rubeis E, Jolly AM, et al. Transmission patterns of HIV and hepatitis C virus among networks of people who inject drugs. PLoS One. 2011;6(7):e22245.","journal-title":"PLoS One"},{"issue":"5","key":"5546_CR46","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1128\/JVI.66.5.3225-3229.1992","volume":"66","author":"M Martell","year":"1992","unstructured":"Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol. 1992;66(5):3225\u20139.","journal-title":"J Virol"},{"issue":"1","key":"5546_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1055\/s-2007-1007262","volume":"15","author":"J Bukh","year":"1995","unstructured":"Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis. 1995;15(1):41\u201363.","journal-title":"Semin Liver Dis"},{"key":"5546_CR48","unstructured":"Baltimore Mayor's Heroin Treatment and Prevention Task Force report. 2015. https:\/\/health.baltimorecity.gov\/sites\/defallut\/files\/Task%20force%20report_071015ull.pdf. Accessed 19 Aug 2020."},{"key":"5546_CR49","doi-asserted-by":"crossref","unstructured":"Novitsky V, Moyo S, Lei Q, DeGruttola V, Essex M. Impact of sampling density on the extent of HIV clustering. AIDS Res Hum Retrovir. 2014;30(12):1226\u201335.","DOI":"10.1089\/aid.2014.0173"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05546-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05546-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05546-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T05:16:08Z","timestamp":1604985368000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05546-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5546"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05546-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]},"assertion":[{"value":"3 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with provisions of the Declaration of Helsinki. It was approved by the Johns Hopkins Bloomberg School of Public Health Institutional Review Board (H.34.01.11.19. A1.). All participants provided written informed consent prior to inclusion in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MS has the following disclosures:\u2022 PI for research grants: Funds paid to Johns Hopkins University: AbbVie, Assembly Bio, Gilead, Proteus Digital Health\u2022 Scientific advisor\/Consultant: The terms of these arrangements are being managed by the Johns Hopkins University in accordance with its conflict of interest policies: AbbVie, Arbutus, GileadOFN, JH, SHM, SDM, GDK, DT, CL, OL, SCR have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"815"}}